Home › Trial NCT00553332
Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery
- Trial IDNCT00553332
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment29
- Start date2007-11
- ConditionsLiver and Intrahepatic Biliary Tract Cancer · Recurrent Extrahepatic Bile Duct Cancer · Unresectable Extrahepatic Bile Duct Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.